A study of patients taking an injectable, long-acting form of an
antipsychotic medication found that within six months of starting
treatment, most patients had switched back to the oral form of
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.